Niall C. Tebbutt
Impact in
- Oncology top 0.1%
- Colorectal Cancer Treatments and Studies
- Colorectal Cancer Surgical Treatments
- Hepatology top 0.5%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
- Oncology 174
- Colorectal Cancer Treatments and Studies 130
- Cancer Treatment and Pharmacology 35
- Colorectal Cancer Surgical Treatments 20
- Pancreatic and Hepatic Oncology Research 18
-
- Gastric Cancer Management and Outcomes 39
- Lung Cancer Treatments and Mutations 33
- Co-authors
- Timothy Price (95 shared papers)John Zalcberg (41 shared papers)Christos S. Karapetis (46 shared papers)Derek J. Jonker (17 shared papers)Malcolm J. Moore (14 shared papers)Dongsheng Tu (14 shared papers)R. J. Simes (11 shared papers)Chris J. O’Callaghan (10 shared papers)
- Journals
- Journal of Clinical Oncology (95 papers)Annals of Oncology (31 papers)British Journal of Cancer (15 papers)Expert Review of Anticancer Therapy (10 papers)Clinical Cancer Research (7 papers)
- Partner nations
- AustraliaUnited StatesUnited Kingdom
In The Last Decade
Niall C. Tebbutt
247 papers receiving 13.0k citations
Niall C. Tebbutt's Hit Papers
Peers
Comparison fields: 5 of 134
- Oncology 8.0k
- Hepatology 1.1k
- Cancer Research 1.6k
- Pathology and Forensic Medicine 1.9k
- Pulmonary and Respiratory Medicine 3.0k
Countries citing papers authored by Niall C. Tebbutt
This map shows the geographic impact of Niall C. Tebbutt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Niall C. Tebbutt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Niall C. Tebbutt more than expected).
Fields of papers citing papers by Niall C. Tebbutt
This network shows the impact of papers produced by Niall C. Tebbutt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Niall C. Tebbutt. The network helps show where Niall C. Tebbutt may publish in the future.
Co-authors
The 25 scholars most cited alongside Niall C. Tebbutt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 260 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | K-ras Mutations and Benefit from Cetuximab in Advanced Colorectal Cancer Hit paper breakdown → | 2008 | 2874 |
| 2 | Cetuximab for the Treatment of Colorectal Cancer Hit paper breakdown → | 2007 | 1466 |
| 3 | Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analysis and Research in Cancers of the Digestive System (ARCAD) database Hit paper breakdown → | 2016 | 455 |
| 4 | 2002 | 415 | |
| 5 | Everolimus for Previously Treated Advanced Gastric Cancer: Results of the Randomized, Double-Blind, Phase III GRANITE-1 Study Hit paper breakdown → | 2013 | 390 |
| 6 | Targeting the ERBB family in cancer: couples therapy Hit paper breakdown → | 2013 | 387 |
| 7 | Bevacizumab in Combination With Chemotherapy As First-Line Therapy in Advanced Gastric Cancer: A Biomarker Evaluation From the AVAGAST Randomized Phase III Trial Hit paper breakdown → | 2012 | 371 |
| 8 | 2006 | 338 | |
| 9 | 2010 | 321 | |
| 10 | 2015 | 257 | |
| 11 | 2010 | 243 | |
| 12 | 2011 | 205 | |
| 13 | 2013 | 187 | |
| 14 | 2011 | 176 | |
| 15 | Evaluation of Combination Nivolumab and Ipilimumab Immunotherapy in Patients With Advanced Biliary Tract Cancers Hit paper breakdown → | 2020 | 162 |
| 16 | 2003 | 152 | |
| 17 | 2013 | 136 | |
| 18 | 2009 | 123 | |
| 19 | 2015 | 123 | |
| 20 | 2004 | 122 |
About Niall C. Tebbutt
Niall C. Tebbutt is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Surgery and Pathology and Forensic Medicine, having authored 260 papers that have together received 13.4k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (130 papers), Gastric Cancer Management and Outcomes (39 papers), Cancer Treatment and Pharmacology (35 papers), Lung Cancer Treatments and Mutations (33 papers), Cancer Genomics and Diagnostics (32 papers), Genetic factors in colorectal cancer (22 papers), Colorectal Cancer Surgical Treatments (20 papers) and Pancreatic and Hepatic Oncology Research (18 papers). The work is most often cited by research in Oncology (8.0k citations), Hepatology (1.1k citations), Cancer Research (1.6k citations), Pathology and Forensic Medicine (1.9k citations) and Pulmonary and Respiratory Medicine (3.0k citations). Niall C. Tebbutt has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include Timothy Price, John Zalcberg, Christos S. Karapetis, Derek J. Jonker, Malcolm J. Moore, Dongsheng Tu, R. J. Simes, Chris J. O’Callaghan, Christiane Langer and Jeremy Shapiro. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, British Journal of Cancer, Expert Review of Anticancer Therapy and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.